IMARC Group has recently released a new research study titled “United States Newborn Screening Market Report by Product (Instruments, Reagents), Technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assay, DNA Assay, Electrophoresis, and Others), Test Type (Dry Blood Spot Test, CCHD, Hearing Screen), and Region 2025-2033”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
United States Newborn Screening Market Overview
The United States newborn screening market size reached USD 109.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 211.0 Million by 2033, exhibiting a growth rate (CAGR) of 7.58% during 2025-2033.
Market Size and Growth
Base Year: 2024
Forecast Years: 2025-2033
Historical Years: 2019-2024
Market Size in 2024: USD 109.3 Million
Market Forecast in 2033: USD 211.0 Million
Market Growth Rate (2025-2033): 7.58 %
Request for a sample copy of the report: https://www.imarcgroup.com/united-states-newborn-screening-market/requestsample
Key Market Highlights:
✔️ Market growth supported by rising awareness of early disease detection in infants
✔️ Growing adoption of advanced genetic & metabolic screening technologies
✔️ Supportive government policies and newborn health programs boosting demand
United States Newborn Screening Market Trends and Drivers:
The United States newborn screening market is witnessing significant advancements as healthcare providers and policymakers recognize the critical importance of early detection of congenital disorders. Newborn screening is a vital public health program aimed at identifying genetic, metabolic, and endocrine disorders that can lead to severe health issues if not addressed promptly. The increasing awareness among parents about the benefits of early screening, coupled with advancements in technology, is driving the demand for comprehensive screening programs across the nation.
Market Size and Projections
The United States newborn screening market size is projected to expand considerably in the coming years. By 2025, the market is expected to grow substantially due to several factors, including the implementation of more extensive screening panels that can detect a wider array of disorders. The rise in healthcare spending and the push for preventive healthcare measures are also contributing to this growth. Additionally, the integration of advanced technologies, such as next-generation sequencing and improved diagnostic tools, is enhancing the efficiency and accuracy of newborn screening processes, further propelling market expansion.
Market Share and Competitive Landscape
In terms of the United States newborn screening market share, key players are actively competing to capture a larger segment of this growing market. Major companies in the healthcare and diagnostics sectors are investing in research and development to innovate and improve their screening technologies. By 2025, it is anticipated that collaborations between public health agencies and private companies will play a crucial role in expanding the market. Furthermore, the increasing adoption of telehealth services is enabling broader access to screening programs, allowing more families to benefit from early detection and intervention.
Future Trends and Opportunities
Looking ahead, the United States newborn screening market growth is expected to be driven by several emerging trends. The focus on personalized medicine and the use of genetic testing are gaining momentum, providing opportunities for tailored screening strategies based on individual risk factors. Additionally, public awareness campaigns aimed at educating parents about the importance of newborn screening are likely to enhance participation rates. By 2025, these trends will create a more robust and comprehensive screening landscape, ultimately improving health outcomes for newborns across the United States.
United States Newborn Screening Market Segmentation:
The market report segments the market based on product type, distribution channel, and region:
Product Insights:
- Instruments
- Reagents
Technology Insights:
- Tandem Mass Spectrometry
- Pulse Oximetry
- Enzyme Based Assay
- DNA Assay
- Electrophoresis
- Others
Test Type Insights:
- Dry Blood Spot Test
- CCHD
- Hearing Screen
Regional Insights:
- Northeast
- Midwest
- South
- West
Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=21054&flag=C
Competitive Landscape:
The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Additionally, detailed profiles of all major companies are included.
Key Highlights of the Report
1. Market Performance (2019-2024)
2. Market Outlook (2025-2033)
3. COVID-19 Impact on the Market
4. Porter’s Five Forces Analysis
5. Strategic Recommendations
6. Historical, Current and Future Market Trends
7. Market Drivers and Success Factors
8. SWOT Analysis
9. Structure of the Market
10. Value Chain Analysis
11. Comprehensive Mapping of the Competitive Landscape
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-201971-6302
